Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
OXFENDAZOLE
Schering Plough Limited
QP52AC02
2.265 %w/v
Oral Suspension
Endoparasiticide
Bovine
1999-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Systamex 2.265 %w/v Worm Drench 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. A white to off-white smooth, uniform suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Indications: A worm drench for cattle and sheep for the control of mature and immature gastro-intestinal roundworms and lungworms and also tapeworms. It is also ovicidal. It controls the following: Gastrointestinal worms: _Ostertagia, Haemonchus, Trichostrongylus, Nematodirus _including _N. battus, Cooperia,_ _Bunostomum, Capillaria, Oesphagostomum, Chabertia _and _Trichuris _spp. Lungworms: _Dictyocaulus viviparous_. Tapeworms: _Monieza _(heads and segments). At the recommended dose in cattle, oxfendazole is effective against inhibited larvae of _Cooperia _and usually effective against inhibited/arrested larvae of _Ostertagia._ In sheep, it is effective against inhibited/arrested stages of _Nematodirus _and benzimidazole susceptible _Haemonchus_ and _Ostertagia._ 4.3 CONTRAINDICATIONS Do not use in animals with known sensitivity to the active ingredient. Active Substance Oxfendazole 2.265 % w/v Excipients Sorbic Acid (E200) 0.150 % w/v Methyl Parahydroxybenzoate (E218) 0.150 % w/v IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 08/10/2010_ _CRN 7006166_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES As with other anthelmintics, veterinary advice should be sought on appropriate dosing programmes and stock management to achieve adequate parasite control and reduce the likelihood of anthelmintic resistance developin Read the complete document